Maintenance of immune tolerance in hemophilia B dogs by subcutaneous administration of recombinant human factor IX (BeneFix) - Russell, DE; Nichols, TC; Elwell, DR; Bellinger, DA; Rup, BJ; Keith, JC; Leitermann, K; McCarthy, KP; Schaub, RG; Read, MS (Blood, 1998)
Suppl 1.